Outcome
    Moderate Evidence

    Tongkat Ali for Sexual Arousal

    Tongkat ali has better trial support than most libido supplements, particularly in stressed or older men.

    Overview

    Tongkat ali is better understood as a desire supplement than an arousal one - it works upstream on drive and hormones rather than on the vascular machinery of arousal itself.
    Randomised placebo-controlled trials of standardised water extract at 200-400 mg daily report improved scores on sexual function questionnaires in men, with a trial in late-onset hypogonadism showing better erectile function and sexual wellbeing. Improvements track alongside modest rises in free testosterone and, in stressed populations, a better testosterone-to-cortisol ratio. Arousal in the physiological sense depends on nitric oxide-mediated vasodilation, and tongkat ali has no demonstrated action there. Where erectile dysfunction is vascular, PDE5 inhibitors work and this does not. The realistic expectation is more interest and less stress-driven suppression, appearing over weeks.

    No studies are currently linked to this pairing

    This page reflects published clinical literature and conventional dosing rather than trial data attached to this outcome in our library.

    How It Works

    Sexual arousal requires androgen signalling to set baseline drive, dopaminergic activation to initiate response, and parasympathetic nitric oxide release to produce genital vasodilation. Stress opposes all three, and cortisol and testosterone move reciprocally under chronic load.
    Eurycomanone and related quassinoids appear to raise free testosterone by displacing it from sex hormone binding globulin and supporting Leydig cell steroidogenesis, with some suggestion of reduced aromatase activity. A separate randomised trial in moderately stressed adults found lower cortisol and improved testosterone-to-cortisol ratio. Neither pathway touches nitric oxide or penile smooth muscle directly, which is the honest mechanistic limit on arousal claims.

    Dosing & Protocol

    Only standardised hot-water extract has trial support; raw root powder is not equivalent.
    ContextDoseFormTiming
    Standard trial dose200 mg dailyStandardised hot-water root extract (about 2% eurycomanone)Morning with food
    Higher studied dose400 mg dailyStandardised water extractMorning, or split morning and midday
    Starting dose100-200 mg dailyStandardised extractMorning for the first two weeks
    Assessment window4-12 weeks-Judge on desire and function scores over weeks, not single occasions

    Spiking is a documented problem

    Sexual-performance botanicals are among the most frequently adulterated products sold, with prescription PDE5 inhibitors and mercury both found in tongkat ali samples. Third-party testing is essential.

    Evidence

    There are currently no studies linked to this pairing in our library, so no study list is shown.
    Several small randomised placebo-controlled trials show improved sexual function and libido questionnaire scores with standardised extract, supported by modest free testosterone increases and cortisol reductions. Reviews of botanical options for male sexual function generally place it among the better-supported entries. The evidence remains limited: samples of thirty to one hundred, durations of four to twelve weeks, heavy reliance on one branded extract with manufacturer involvement, self-reported endpoints susceptible to placebo response, no comparison against PDE5 inhibitors, almost no data in women, and no long-term follow-up.

    Desire yes, vascular arousal untested

    Reasonable small-trial support for libido and function scores. No evidence of direct effect on arousal physiology.

    Safety

    Standardised extract is generally well tolerated at 200-400 mg daily over the studied periods. Insomnia, restlessness, irritability and mild digestive upset are the usual complaints and are reduced by morning dosing.

    New erectile dysfunction is a cardiovascular warning sign

    It often precedes coronary disease by several years and can also indicate diabetes or low testosterone. Get assessed rather than self-treating.

    Avoid in prostate cancer and other hormone-sensitive conditions given the potential rise in free testosterone, and use caution in significant benign prostatic hyperplasia. Mercury contamination has been documented in market samples, and safety in pregnancy, breastfeeding and liver or kidney disease is unestablished.

    Interactions & Conflicts

    Hormonal, stimulant and cardiovascular considerations dominate.
    Interacts withSeverityMechanismAction
    Prostate cancer or hormone-sensitive conditions
    high
    		May raise free testosteroneAvoid without specialist advice
    Testosterone replacement therapy
    moderate
    		Additive androgenic effect, no demonstrated benefitNo reason to combine
    PDE5 inhibitors
    low
    		Different mechanisms; adulterated products may already contain themUse only verified product; discuss combining with a clinician
    Antihypertensives
    moderate
    		Reported blood pressure effectsMonitor blood pressure
    Evening dosing and caffeine
    moderate
    		Insomnia lowers testosterone and libidoDose in the morning

    References

    No studies are currently linked to this pairing, so no reference list is available. This section will populate as evidence is added to the library.

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.